Miller Law and co-lead class counsel have negotiated a proposed settlement with defendant GlaxoSmithKline (GSK) in this class action lawsuit regarding the prescription nasal spray Flonase.  The lawsuit claims that the seller of Flonase violated state laws by delaying the availability of generic versions of Flonase.  The seller is SmithKline Beecham Corporation doing business as GSK.  GSK denies it has done anything wrong, but has agreed to settle the claims in the lawsuit for a total of $35 million.  This includes the claims of consumers and health insurers, which are referred to as Third-Party Payors in the Class.  Additional information can be found here.